Notice of Correction in Expiration Date for PAR-22-049, "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)"
Notice Number:
NOT-CA-22-008

Key Dates

Release Date:

November 2, 2021

Related Announcements

PAR-22-049 - Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

This Notice corrects the expiration date for Funding Opportunity Announcement (FOA) PAR-22-049, "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)".

The following modification has been made to PAR-22-049 to reflect the corrected expiration date:

Currently Reads:

Part 1. Overview Information

Key Dates

Expiration Date: September 14, 2023

Modified to Read (change shown in bold italics):

Part 1. Overview Information

Key Dates

Expiration Date: September 14, 2024

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Lokesh Agrawal, PhD
National Cancer Institute (NCI)
Telephone:240-276-5718
Email: lokesh.agrawal@nih.gov

Abhi Rao, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5715
Email: abhi.rao@nih.gov

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov

Financial/Grants Management Contact(s)

Shane Woodward
National Cancer Institute (NCI)
Telephone: 240-276-6303
Email: Shane.Woodward@nih.gov